Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Home - The Pharma Times | Pharma & Health Care News Portal
Thursday, April 25, 2024

India Needs Stringent Regulation & Certification-Mechanism to Ensure Authenticity of Personal...

Need to scan whether the new age personal care proclaimed natural products are natural: Say mothers New Delhi, September 25, 2020: An oft-repeated maxim — 'Cleanliness...

Biotechnology

Conjunctivitis at its peak by NIIMS

New Delhi, August 17, 2023: Conjunctivitis or pink eyes or red eyes is spreading at a fast rate. It is highly infectious and might...

IT & Software Support

Appointments

New Sales Director at RomacoPharmatechnik GmbH Volker Brück

New Delhi, September 19, 2019: Volker Brück has been appointed new Sales Director of Karlsruhe (Germany) based RomacoPharmatechnik GmbH. He will in future be...

Swiss based Pharma Veteran, Balasubramanian Srinivasan (Srini Srinivasan) joins TAKE Solutions Board as an...

Chennai, December 07, 2019: TAKE Solutions Ltd. , a globally recognized domain intensive services provider in Life Sciences, today announced the appointment of Srini Srinivasan...

Awards

Sepsivac® receives Covid-19 Pharma Excellence Award

Ahmedabad, August 26, 2020: Sepsivac®,the latest innovation Cadila Pharmaceutical recently received the prestigious Pharma Excellence Awardat the Emerging Dimensions in Pharma Excellence e-Summit organised...

Financial Results

Torrent Pharma announces Q3 FY22 results

Continued pressure on US business offsets robust India performance Revenues & profitability: Revenue at 2,108 crores...

Lincoln Pharmaceuticals Ltd reports 28.33% rise in the Standalone Net Profit at Rs.11.85 crore in Q4 FY21

Company recommends dividend of 15% - Rs. 1.5 per share for FY 21 Net Revenues...

Approvals

Clinical Trails

Phase III DECISION Trial of Nexavar® (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival...

Berlin, January 3, 2013 – Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that a Phase III trial of Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory differentiated thyroid cancer has met its primary endpoint of a statistically significant improvement in progression-free survival. The study, called DECISION, evaluated the efficacy and safety of Nexavar compared to placebo. The safety and tolerability were generally consistent with the known profile of Nexavar. Detailed efficacy and safety analysis from this study are expected to be presented at an upcoming medical meeting. Effective treatment options are urgently needed for patients with RAI-refractory differentiated thyroid cancer,” said Dimitris Voliotis, MD, Vice President, Global Clinical Development Oncology, Bayer HealthCare. “We are pleased that the results of this study demonstrate that Nexavar may provide a treatment option for these patients.

Bulk Drug

Health Care

Alternative Medicine

Eye Care

Conjunctivitis at its peak by NIIMS

New Delhi, August 17, 2023: Conjunctivitis or pink eyes or red eyes is spreading at a fast rate. It is highly infectious and might...

Kids with Autism have higher chances of eye disorders Study...

New Delhi,  january 03, 2024 :  Autism spectrum disorder (ASD) is a condition that not only affects the child's behaviour but also has a significant...

Product News

Cholesterol Beats Swine Flu, Avian Flu and Corona Viruses – Viroblock Launches New Face...

New Delhi, Delhi, June 2013: Viroblock SA, a Swiss start-up, today presented new data at ICPIC 2013 in Geneva, showing that their face-mask containing proprietary novel cholesterol depletion technology traps and kills over 99.9995% of H1N1 flu viruses (swine flu), 99.999% of H5N1 flu viruses (avian flu) and 99.997% human corona viruses on pass through air. Aimed at helping protect people from these respiratory pathogens, the mask is up to one hundred times more effective than a similar mask without Viroblock technology. The company will now start direct sales in Switzerland and is looking for distributors in other countries.

Eisai to Present Abstracts on Oncology Products and Pipeline at ESMO 2019 Congress

Tokyo, September 29, 2019: Eisai Co., Ltd. announced today that a series of abstracts will be presented during the European Society for Medical Oncology...

Media Partners

Spotlight

Investments

Packaging

Latest News

Reconstructive Surgery in Oral Cancer: Restoring Function and Aesthetics

 Dr Nikhil Mehta , Consultant Surgical Oncologist, HCG Cancer Centre, Jaipur  The diagnosis of oral cancer is a life-altering event that not only poses a threat...

A 3-day-old neonate undergoes complex cardiac surgery

Hyderabad, November 10, 2023:  A 3-day-old neonate, who has an extremely rare combination of two major lesions in the heart was successfully operated on...

Apollo Hospitals and Medtronic Partner to Advance Stroke Management Using Artificial Intelligence (AI)

~ Medtronic will support Apollo Hospitals with technical expertise, training and setting up of comprehensive stroke centers aiming at reducing door to needle time...

Dental Care

Hospital Management

HCG Cancer Hospital completes Comprehensive Genomic Profi­ling (CGP) of 1000+ Cancer Patients

Bengaluru , August 22, 2023: Envisioned to drive a new standard of cancer care, Triesta Sciences, a Unit of HealthCare Global Enterprises Limited (HCG Cancer...

Drug Discovery & Development

Developments in Bio-informatics will help drive discoveries

    • Training,  revamp  of  University  system,  Promote  Translation  of  Academicre search, Promoting Bio-Entrepreneurship will accelerate the industry growth

 

  • Synthetic  Biotechnology  has  tremendous  potential,  affordable  gene  sequencing can play a major role in the Food, Energy, fragrance & Flavors

The Illustrated Guide to Living with Diabetes in India, a Self-management Guide for Diabetics...

Mumbai, Maharashtra, India, Monday, April 22, 2013 -- (Business Wire India) -- 'The Illustrated Guide to Living with Diabetes in India', a practical guide to self-manage diabetes was launched at Kochi on Friday, April 19, 2013 by Sir Michael Hirst, President, International Diabetes Federation (IDF) during the 5 th World Congress of DiabetesIndia. Dr. Shaukat Sadikot, President - Elect, IDF and Prof. Dr. Jean Claude Mbanya, Past-President, IDF was also present during this occasion. The book authored by The Living with Diabetes in India (LWDI), an online community for people with diabetes with over half a million members - and co-published in India by Popular Prakashan, is now available at leading book stores across India and through online retailers.

Suppliers

Technology

Companies

Dr Anju Sharma gave Sound Healing Session to Tihar Inmates on...

New Delhi, October 12, 2021: In today's time, meditation, mindfulness, and thoughtful practices have proved to be the key to fighting the insanity and...

Impact Biomedical’s Majority Owned Next Generation Medical Technologies Valued at USD...

Singapore, April 28, 2020 : (ACN Newswire) - SGX-listed Singapore eDevelopment Ltd's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc., announced recently that their...

Marketing

Our Partners

Machinery & Equipments